Impaired Fibrinolysis in Angiographically Documented Coronary Artery Disease

Table 3

Plasma fibrinolysis markers considering stenosis of 70% as clinical cut point for intervention.

	Stenosis < 70%	Stenosis > 70%
	66	57	—
PAI-1	37.55 (30.90; 49.20)	66.60^a (44.70; 91.65)
TAFI	5.20 (4.37; 6.31)	4.53^a (4.04; 5.63)

= sample size; PAI-1 = type 1 plasminogen activator inhibitor; TAFI = thrombin activatable fibrinolytic inhibitor; versus stenosis <70%. Values for PAI-1 and TAFI are given in median (25th and 75th percentiles) and expressed in ng/mL and μg/mL, respectively.